Tumor that arises from specialized body cells, called neuroendocrine cells, is known as neuroendocrine tumor. Neuroendocrine tumor arises from cells that produce hormones; thus, it produces and releases hormones into the blood in response to signals received from the nervous system. It can occur anywhere in the body, but most commonly occurs in pancreas, digestive tract, lungs, rectum, and appendix. Neuroendocrine tumor can be either benign (non-cancerous) or malignant (cancerous). Types of neuroendocrine tumors are islet cell tumors, carcinoid tumors, pheochromocytomas, medullary thyroid cancer, neuroendocrine carcinoma, and others. Neuroendocrine tumors are a rare kind of tumor. It is estimated that more than 12,000 people are affected by neuroendocrine tumors each year in the U.S. Growing prevalence of neuroendocrine tumors is expected to drive the growth of the market during forecast period. In addition to it, significant increase in funding by various international organizations, such as, the World Health Organization and the American Cancer Academy is projected to boost the neuroendocrine tumors market in the near future. Drugs used for the treatment of rare diseases are known as orphan drugs. Rare diseases affect very small portion of population. Therefore, unlike non-orphan drugs, orphan drugs do not gurantee return on investment. Furthermore, compared to non-orphan drugs, the cost of development of orphan drugs is significantly higher, which is expected to hamper the growth of the neuroendocrine tumors market during the forecast period.
The global neuroendocrine tumors market can be segmented based on type, treatment, and geography. In terms of type, the market can be divided into merkel cell cancer, neuroendocrine carcinoma, pheochromocytoma, and others. The neuroendocrine carcinoma segment is anticipated to hold a significant share of the neuroendocrine tumors market during the forecast period, as around 60% of neuroendocrine tumor cases pertains to neuroendocrine carcinoma. Based on treatment, the global neuroendocrine tumors market can be calssified into surgery, radiation therapy, and chemotherapy. Surgery is the main treatment prescribed for neuroendocrine tumor. Chemotherapy is a combination of drugs used for the treatment of neuroendocrine tumors. Streptozocin and 5-fluorouracil are examples of drugs used in the treatment of neuroendocrine tumor. Several clinical trials are underway to study new drugs for the treatment of neuroendocrine tumors. Approval or launch of new drugs is expected to drive the neuroendocrine tumors market during the forecast period. However, disappointing results of strong pipeline molecules are expected to restrain the growth of the market.
Based on geography, the global neuroendocrine tumors market can be classified into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America dominates the global neuroendocrine tumors market, followed by Europe. Key drivers of the market in these regions are rising incidence of diseases, developed health care infrastructure, strong clinical pipeline, high level of awareness among people, presence of key market players, and increase in government expenditure. The neuroendocrine tumors market in Asia Pacific is expected to grow rapidly during the forecast period due to large patient base, developing health care infrastructure, and rising government expenditure in health care in the region. Morover, increasing focus of key players for business expansion propels the growth of the neuroendocrine tumors market in Asia Pacific. In Latin America and Middle East & Africa, lack of proper treatment facilities, low income level, and poor patient education are likely to hamper the growth of the neuroendocrine tumors market in the next few years.
Major players operating in the global neuroendcriens tumors market include F. Hoffmann-La Roche Ltd., Bristol-Myers Squibb, Eli Lilly & Company, Novartis AG, Pfizer Ltd., Amgen, Inc., Ispen SA, Teva Pharmaceuticals, Ltd., Callisto Pharmaceuticals Pvt. Ltd., and Biosynthema, Inc.
The report offers a comprehensive evaluation of the market. It does so via in-depth qualitative insights, historical data, and verifiable projections about market size. The projections featured in the report have been derived using proven research methodologies and assumptions. By doing so, the research report serves as a repository of analysis and information for every facet of the market, including but not limited to: Regional markets, technology, types, and applications.
The study is a source of reliable data on:
- Market segments and sub-segments
- Market trends and dynamics
- Supply and demand
- Market size
- Current trends/opportunities/challenges
- Competitive landscape
- Technological breakthroughs
- Value chain and stakeholder analysis
The regional analysis covers:
- North America (U.S. and Canada)
- Latin America (Mexico, Brazil, Peru, Chile, and others)
- Western Europe (Germany, U.K., France, Spain, Italy, Nordic countries, Belgium, Netherlands, and Luxembourg)
- Eastern Europe (Poland and Russia)
- Asia Pacific (China, India, Japan, ASEAN, Australia, and New Zealand)
- Middle East and Africa (GCC, Southern Africa, and North Africa)
The report has been compiled through extensive primary research (through interviews, surveys, and observations of seasoned analysts) and secondary research (which entails reputable paid sources, trade journals, and industry body databases). The report also features a complete qualitative and quantitative assessment by analyzing data gathered from industry analysts and market participants across key points in the industry’s value chain.
A separate analysis of prevailing trends in the parent market, macro- and micro-economic indicators, and regulations and mandates is included under the purview of the study. By doing so, the report projects the attractiveness of each major segment over the forecast period.
Highlights of the report:
- A complete backdrop analysis, which includes an assessment of the parent market
- Important changes in market dynamics
- Market segmentation up to the second or third level
- Historical, current, and projected size of the market from the standpoint of both value and volume
- Reporting and evaluation of recent industry developments
- Market shares and strategies of key players
- Emerging niche segments and regional markets
- An objective assessment of the trajectory of the market
- Recommendations to companies for strengthening their foothold in the market
Note: Although care has been taken to maintain the highest levels of accuracy in TMR’s reports, recent market/vendor-specific changes may take time to reflect in the analysis.